Burden of neurological disorders across the US from 1990-2017: a global burden of disease study

VL Feigin, T Vos, F Alahdab, AML Amit… - JAMA …, 2021 - jamanetwork.com
Importance Accurate and up-to-date estimates on incidence, prevalence, mortality, and
disability-adjusted life-years (burden) of neurological disorders are the backbone of …

Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001

MD Redelings, L McCoy, F Sorvillo - Neuroepidemiology, 2006 - karger.com
Multiple sclerosis (MS) is a neurodegenerative condition that can result in cognitive and
physical disability and shortened life expectancy. However, population-based information is …

Multiple sclerosis: prevalence and impact

H Gilmour, PL Ramage-Morin, SL Wong - Health reports, 2018 - search.proquest.com
This article provides new information about multiple sclerosis (MS) using the 2010/2011
Neurological Conditions Prevalence File, the 2011/2012 Survey of Neurological Conditions …

Regional variation of multiple sclerosis prevalence in Canada

CA Beck, LM Metz, LW Svenson… - Multiple Sclerosis …, 2005 - journals.sagepub.com
Objective: To describe the regional distribution of multiple sclerosis (MS) prevalence in
Canada, controlling for age and sex. Methods: This study used data from the Canadian …

The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs

B Bebo, I Cintina, N LaRocca, L Ritter, B Talente… - Neurology, 2022 - AAN Enterprises
Background and Objectives A recent report estimated that approximately 1 million adults
were living with multiple sclerosis (MS) in the United States. Although MS is rarely the direct …

Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia

RA Marrie, BN Yu, S Leung, L Elliott… - Multiple Sclerosis …, 2012 - journals.sagepub.com
Background: Despite the importance of comorbidity in multiple sclerosis (MS), methods for
comorbidity assessment in MS are poorly developed. Objective: We validated and applied …

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis: a meta-analysis study

R Zivadinov, L Iona, L Monti-Bragadin, A Bosco… - …, 2003 - karger.com
Objective: To demonstrate whether or not the age and sex adjustment of incidence and
prevalence rates in multiple sclerosis (MS) could allow more reliable comparison between …

Infections in patients diagnosed with multiple sclerosis: a multi-database study

R Persson, S Lee, MU Yood, CM Wagner… - Multiple sclerosis and …, 2020 - Elsevier
Background Recent data on the rates of infections among patients with multiple sclerosis
(MS) are sparse. The objective of this study was to quantify incidence of infections in patients …

Incidence, prevalence, and geographical clustering of motor neuron disease in the Netherlands

AD de Jongh, RPA van Eijk, SM Peters, MA van Es… - Neurology, 2021 - AAN Enterprises
Objective To assess time trends in motor neuron disease (MND) incidence, prevalence, and
mortality and to investigate geographic clustering of MND cases in the Netherlands from …

High nationwide prevalence of multiple sclerosis in Sweden

C Ahlgren, A Odén, J Lycke - Multiple Sclerosis Journal, 2011 - journals.sagepub.com
Background: Few nationwide multiple sclerosis (MS) prevalence studies have been
published. In Scandinavia, the nationwide MS prevalence was 173/100,000 in Denmark …